We have shown previously the importance of MHC class II for central nervous system remyelination; however, the function of MHC class II during cuprizone-induced demyelination has not been examined. Here, we show that I-A β −/− mice exhibit significantly reduced inflammation and demyelination. RAG-1 −/− mice are indistinguishable from controls, indicating T cells may not play a role. The role of MHC class II depends on an intact cytoplasmic tail that leads to the production of IL-1β, TNF-α, and nitric oxide, and oligodendrocyte apoptosis. Thus, the function of MHC class II cytoplasmic tail appears to increase microglial proliferation and activation that exacerbates demyelination.
Introduction
The Major Histocompatibility Complex class II (MHC II) molecules present antigenic peptides to CD4 + T cells through interactions with both the T cell receptor (TCR) and the CD4 molecule (Doyle and Strominger, 1987; Germain, 1994; Jones et al., 2006; Konig et al., 1992 Konig et al., , 1995 . Enhancement of MHC class II has been found to be important for the education of CD4 + T cells and T cell-mediated immune responses, while the elimination of MHC II is frequently associated with the ablation of such responses (Grusby and Glimcher, 1995) . Previous in vivo studies have primarily focused on the effects of MHC II antigens as ligands for the TCR and not as a receptor for signaling cell activation (Thomson, 1995; Zamvil et al., 1985) . MHC II molecules have been observed in mouse brains (Hauser et al., 1983; Hickey and Kimura, 1988; Ting et al., 1981; Wong et al., 1984) and in a number of neurological disorders (Hickey, 1991; Mattiace et al., 1990; McGeer et al., 1988a,b) . In diseases involving viral infections or experimental autoimmune encephalitis (EAE), where T cell involvement is prominent, the function of MHC II is primarily that of antigen presentation by microglia/macrophages (Fritz and McFarlin, 1989; Zamvil and Steinman, 1990) . Unlike normal mouse brain, there is little to no expression of MHC II in healthy human brain (Kreutzberg, 1996) ; yet in neurological disorders, such as Alzheimer's disease, Huntington's disease, and Parkinson's disease, MHC II + microglial/macrophage cells are present. Interestingly, T cells do not appear to be involved in these CNS disorders (Hickey et al., 1991; Mattiace et al., 1990; McGeer et al., 1988a,b; Zamvil et al., 1985) . In addition, even in MS lesions, microglia/macrophages have been found in the absence of significant T cell infiltration (Barnett et al., 2006; Li et al., 1993; Prineas et al., 2002; Raine, 1994) . Thus, the function of MHC II and the significance of T cells in these diseases are important issues that need to be clarified. 
